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Abstract
Background: In vitro studies show that new miniature cryoprobes are suitable for cryoablation
of bone tissue. The aim of this animal trial on 24 sheep was to examine the perioperative
complications, particularly the danger of embolism, of cryoablation when using miniature
cryoprobes.
Methods: Cryoablations with 2 freeze-thaw cycles each were carried out in the epiphysis of the
right tibia and the metaphysis of the left femur. Pulmonary artery pressure (PAP) and central
venous pressure (CVP) were measured. Throughout the intra- and perioperative phase, heart rate
and oxygen saturation by pulse oxymetry, blood gas and electrolytes were monitored regularly.
Postoperative complications were examined up to 24 weeks postoperativ.
Results: As result, no significant increase of PAP, CVP or heart rate were observed. Blood gases
were unremarkable, with pO2 and pCO2 remaining constant throughout the operation. Regarding
pH, standard bicarbonate and base excess, only a non-significant shift towards a slight acidosis was
seen. There was a mean hemoglobin decrease of 0.5 g/dl. One animal showed postoperative wound
infection and wound edge necrosis. No major peri- and postoperative complications associated
with cryosurgery of bone were observed, especially regarding clinically relevant pulmonary
embolism.
Conclusion: Surgery with new types of miniature cryoprobes appears to be a safe alternative to
or a complement to conventional resection of abnormal bone tissue.
Background
Surgical treatment of bone tumours often requires gener-
ous resection of bone, leaving defects which are difficult
to span. Freezing tumours with liquid nitrogen was intro-
duced in the late 1960's as an adjuvant treatment to
extend the surgical margin of excision for intralesional
resection or for curettage by pouring or spraying the nitro-
gen directly into the bone cavity [1-9]. Animal trials by
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Gage et al. [10] have shown that devitalised bone matrix
can serve as a framework for new periostal and endostal
growth, and hence that the former tumour space can be
bridged with autologous, healthy bone tissue. However,
the freezing procedure is difficult to control, and therefore
harbours risks of injury for the patient [11,12] and the sur-
gical team, as well as of gas embolisms caused by evapo-
ration [13] and spread of the liquid nitrogen.
Aside from the open use of liquid nitrogen, closed systems
for treating bone tumours have also been used [14],
although they never became popular because the cooling
power of the cryoprobes then used was low compared to
their diameter [15]. Recent technical advances [16] made
it possible for us to develop new probes for cryoablation
of bone tissue and test these in animal trials [17,18]. The
efficiency of these procedure and the extent of tissue
distruction is well documented in a former study with a
comparable setup [19].
Various complications have been reported, ranging from
soft tissue wound infection and fractures [20] to bone
marrow and fat embolism caused by the spread of the ice
front due to an increase in intramedullar pressure [21].
These miniature cryoprobes with a minimised diameter
allow precise control of the freezing process, thus avoid-
ing uncontrolled freezing of soft parts and healthy bone
tissue, as well as a sudden expansion of the ice front. Aim
of this animal trial was to determine whether the use of
modern miniature cryoprobes can avoid the above
described complications.
Methods
A commercially available cryotherapy system (Erbokryo
CS-6-System, Erbe, Tübingen, Germany) was used for cry-
oablation. This system consists of a casing with a control
board and up to 6 vacuum-isolated flexible tubes with a
cryoprobe (diameter 3.2 mm) at the end. A cryoprobe cre-
ates a cold zone 3 cm long. The Erbokryo is also fitted with
computer-controlled temperature sensors (diameter 1.2
mm) witch allow 6 simultaneous measurements.
The cryoprobes were introduced via an access hole 3.6
mm in diameter drilled perpendicular to the cortical sub-
stance. Temperature was measured inside the cortical sub-
stance. Two 15-minute freezing cycles were done with the
probe at full power, with a 6-minute thaw in between.
Prior to starting the cryoablation, the position of the cry-
oprobe was checked radiologically and recorded.
24 sheep with a mean weight of 61 kg (range 39–78 kg)
were placed under general anaesthesia and, using a single
cryoprobe introduced through a lateral access hole, one
cryoablation was done in the distal diametaphyseal tran-
sitional region of the head of the medial left tibia and the
right femur of each sheep. For the tibial head, a medial
access hole was drilled and the cryoprobe introduced cen-
trally 1.5 cm below the joint and pushed to the other side
of the cortical substance.
For the femoral cryoablation, the cryoprobe was intro-
duced through a distal, posterolateral access hole in the
area of the linea aspera at the diametaphyseal transition.
In addition, 4 temperature sensors were introduced
through access holes drilled radially at 1 cm from the bore
hole. The cryoprobes were only introduced 1 cm into the
bone to avoid freezing the cortical substance. Thus, the
necrosis zone (which roughly corresponds to the -10°C
isotherm [24]) only comprised an area of 2.4 × 2.4 in the
outer cortical substance. Control holes and access holes
were drilled on the contralateral sides (left femur, head of
the right tibia).
All operations were done under 600 mg clindamycin i.v.
and 12 hours prior to surgery, each animal also received
thrombosis prophylaxis (0.3 ml nadroparin calcium
[Fraxiparin®] s.c.). There was no postop thrombosis
prophylaxis since all animals were fully mobile after
anaesthesia. The pulmonary-arterial pressure (PAP) and
the central venous pressure (CVP) were measured via a
pulmonary catheter inserted into the jugular vein. Meas-
urements were done before the first cryoablation (1, Fig.
1, 2, 3), after the first cryoablation on the right femur (2,
Fig. 1, 2, 3) and the head of the left tibia (3, Fig. 1, 2, 3),
as well as after drilling the control holes immediately after
shifting the animals from the right back to the left unilat-
eral recumbent position (4, Fig. 1, 2, 3). Intra- and periop-
erative monitoring was complemented by measurements
of heart rate (Fig. 3) and oxygen saturation via pulse
oxymetry, as well as blood counts (Fig. 4), deep body tem-
perature (Fig. 5), blood gases and electrolytes after each
cryoablation. Postoperative complications were moni-
tored clinically. 8 animals were sacrificed at 8, 16 and 32
weeks postop and tissue samples taken from the lungs and
from blood vessels in the areas of cryoablation were exam-
ined for signs of embolism. Samples were taken from each
lobe and from the femoral vein, fixed in formaline and
stained with hematoxylin and eosin (HE). Furthermore,
the ablation sites were examined histologically for infec-
tion of the soft tissue respectively osteomyelitis. X-rays
were taken after the animals were sacrificed.
Results
Mean duration of operation was 4 h 22 min, mean dura-
tion of anaesthesia 5 h 13 min. In 18 of 24 cases, the mean
pulmonary-arterial pressure PAP and the mean central
venous pressure (CVP) showed no significant changes at
any of the 4 sampling times (Figs. 1 and 2). The PAP rose
in 2 animals while in 4 other cases, the haemodynamics
could not be determined for technical reasons. There wasBMC Surgery 2005, 5:17 http://www.biomedcentral.com/1471-2482/5/17
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only a temporary increase of the mean PAP and CVP while
the animals were in the right unilateral recumbent posi-
tion, but all values normalised when the animals were
shifted to their left side. The heart increased marginally
during the operation (Fig. 3).
Blood gas analysis showed an increase in pCO2 at con-
stant oxygen saturation after the animals were shifted to
their right side. In 5 of the animals, the pCO2 remained
slightly higher even after they were shifted to their left
side. PH, base excess, electrolytes and lactate showed no
changes at any sampling time. Hemoglobin decreased
marginally (Fig. 4). The deep body temperature (taken
central-venously) before and after cryosurgery was not
obviously related to any single cryoablation, but it did
Mean central venous pressure (CVP): Measurements were  done before (point 1) and after the two cryoablations (point  2, 3) and after drilling the controll holes (point 4) Figure 1
Mean central venous pressure (CVP): Measurements were 
done before (point 1) and after the two cryoablations (point 
2, 3) and after drilling the controll holes (point 4).
Mean pulmonary artery pressure (PAP) before (point 1) and  after the two cryoablations (point 2, 3) and after drilling the  controll holes (point 4) Figure 2
Mean pulmonary artery pressure (PAP) before (point 1) and 
after the two cryoablations (point 2, 3) and after drilling the 
controll holes (point 4).
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Mean heartrate measured at different times of the operation 
(see fig. 1, 2).
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Mean hemoglobin (HB) measured before and directly after 
the operation.
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show a mean decrease of 1.25°C over the course of the
entire operation (Fig. 5). Clinical follow-up observations
yielded no remarkable findings. The mean time of recov-
ery – i.e., from the end of anaesthesia until the animals
were able to stand up again – was 86 minutes. None of the
24 animals showed any clinically significant respiratory
insufficiency. One animal developed a severe wound
infection which required treatment. The wound was
excised and showed secondary healing under antibiotics
(Fig. 6).
Autopsy revealed clean scars in all animals. There were
macroscopically and microscopically no signs of ongoing
or resolved osteomyelitis. All vein samples were free of old
or recent thrombi. The lungs were grossly unremarkable.
Histology of the bronchopulmonary arteries showed no
evidence of acute or cronic embolism or thrombus. Thus,
none of the animals had suffered an embolism even at the
segment level. Some did show a marked bronchial pneu-
monia, although it followed an asymptomatic course and
was therefore of no consequence. No animal showed
spontaneous fractures, and X-rays taken at the end of the
trial revealed no evidence of healed fractures.
Discussion
Intravasation of adipose tissue or bone marrow can lead
to acute blockage of pulmonary microcirculation, with
increased resistance in the arterial pulmonary capillaries
and a secondary increase of pressure in the pulmonary
artery and the right atrium [22]. This causes the pCO2 to
rise and oxygen saturation to decrease, with tachycardia
resulting from left ventricular volume deficiency. To date,
no comparable trials on large animals have been done
examining cryoablation in bone tissue with modern cryo-
probes. Kerschbaumer et al. [23] found no lung embo-
lisms in rabbits after cryosurgery. On the other hand,
Oeseburg also used rabbits and observed a large number
of bone marrow embolisms in the extraosseous veins
immediately after cryoablation [21].
One of the aims of this study was the detection of larger,
clinically significant lung embolisms, we restricted our-
selves to venously measurable hemodynamic parameters
so as not to cause additional, iatrogenic complications.
Likewise, we decided against a transesophageal ultra-
sound probe for detecting microemboli [24,25] since the
animals already were administered a large transesopha-
geal tube to aspirate gastric juices during the operation,
thus leaving no room for an ultrasound probe.
Mean deep temperature measured before and after the  operation Figure 5
Mean deep temperature measured before and after the 
operation.
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Superficial wound infection 2 weeks after cryosurgery Figure 6
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None of the animals showed histological evidence of lung
embolisms, nor were any embolism-specific hemody-
namic phenomena or blood gas changes observed. The
rise in pCO2 seen in all animals at the end of the operation
is likely to be due to the impaired pulmonary gas
exchange and decreased venous flow resulting from the
increased intraabdominal pressure, which in turn can
probably be attributed to the distended rumen during
while the animals were lying on their right side. The rise
in pCO2 explains the slight acidosis which the animals
showed towards the end of the operation, and is therefore
not to be seen as pathological.
In our opinion, the absence of significant embolisms is
due to the small diameter of the probe, which prevents the
intramedullar pressure from rising when the probe is
introduced. A further reason could be the controlled
expansion of the ice front in the bone, which prevents
intramedullar pressure from peaking, and hence bone
marrow or adipose tissue from being pressed out of the
marrow cavity.
As expected, we did not observe any decrease in body tem-
perature after cryosurgery as was reported for small ani-
mals such as mice and rats [26]. The minimal reduction in
body temperature which we did see towards the end of the
operation can be explained by the normal cooling of the
body despite a heating pad. We believe that the more pro-
nounced decrease in body temperature in small animals is
due to their smaller body volume, next to which the cryo-
probe is comparatively much larger. Hence, the results of
our trials with large animals can be extrapolated more
readily to human patients than can results from similar
trials with small animals, and a significant decrease in
body temperature is not to be expected in human patients.
Except for hemoglobin, all blood chemistry values
remained essentially unchanged during the operation.
The drop in hemoglobin by on the average 0.5 g/dl is not
clinically significant.
Clinical follow-up revealed one serious wound infection,
which underscores the tendency these wounds have for
infection [20]. Even so, it would seem to us that the risk of
infection can be controlled with perioperative
administration of antibiotics, as is also evident from the
histology of the treated bone sections, none of which
developed acute inflammation. Nevertheless, it must be
admitted that the tissue treated here was healthy bone in
animals with an intact immune system, and a higher
infection rate must be expected when applying this
method to patients with advanced malignancy.
Convalescence after cryosurgery is associated with
changes in bone stability, a topic which few studies have
addressed so far. Gage et al. (1967) reported 11 spontane-
ous fractures in 20 dogs, where the entire cross-section of
the femur was frozen over a length of 4.5–7 cm [9]. Fur-
ther studies report a maximum reduction in bone stability
some 8 weeks after cryosurgery [27,20]. The absence of
fractures in our trial shows that limiting bone necrosis by
controlled freezing and minimum tissue loss when intro-
ducing the cryoprobe helps minimise the reduction in
bone stability, and hence prevent fractures. To be sure, the
size of a tumour dictates the extent of the freezing zone, so
that stabilising measures may be necessary.
Conclusion
In conclusion the use of modern miniature cryoprobes for
cryoablation of bone tissue seems to be a gentle method,
and the complications reported for earlier systems did not
occur in this study. Therefore, this cryosurgical technique
has a pontential in human subjects and could be usefull
either to complement conventional resections, or else as a
minimally invasive alternative procedure.
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